Castle Biosciences Inc. (CSTL)
20.13
+0.52 (2.65%)
Upcoming Events
Latest Headlines
Form EFFECT CASTLE BIOSCIENCES INC
April 17, 2024 6:04 AM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Apr 12 Filed by: MAETZOLD DEREK J
April 16, 2024 4:47 PM - SEC Filing
Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J
April 12, 2024 4:37 PM - SEC Filing
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
April 11, 2024 7:00 AM - BizWire
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
April 10, 2024 5:00 PM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Apr 08 Filed by: BRADBURY DANIEL
April 10, 2024 4:35 PM - SEC Filing
Form ARS CASTLE BIOSCIENCES INC For: Apr 10
April 10, 2024 4:09 PM - SEC Filing
Form DEFA14A CASTLE BIOSCIENCES INC
April 10, 2024 4:08 PM - SEC Filing
Form DEF 14A CASTLE BIOSCIENCES INC For: Apr 10
April 10, 2024 4:07 PM - SEC Filing
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
April 10, 2024 7:00 AM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Apr 04 Filed by: BRADBURY DANIEL
April 8, 2024 4:32 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Apr 03 Filed by: MAETZOLD DEREK J
April 5, 2024 4:38 PM - SEC Filing
Form 144 CASTLE BIOSCIENCES INC Filed by: BRADBURY DANIEL
April 4, 2024 5:02 PM - SEC Filing
Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer
April 4, 2024 4:30 PM - BizWire
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 2, 2024 7:00 AM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Mar 26 Filed by: Cotton Rodney
March 28, 2024 4:45 PM - SEC Filing
Form 3 CASTLE BIOSCIENCES INC For: Mar 26 Filed by: Cotton Rodney
March 28, 2024 4:36 PM - SEC Filing
Form 8-K CASTLE BIOSCIENCES INC For: Mar 26
March 27, 2024 5:05 PM - SEC Filing
Castle Biosciences (CSTL) Appoints Rodney Cotton to its Board
March 27, 2024 5:01 PM - StreetInsider
Castle Biosciences Announces Updates to its Board of Directors
March 27, 2024 5:00 PM - BizWire
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
March 25, 2024 7:00 AM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Mar 20 Filed by: MAETZOLD DEREK J
March 22, 2024 5:17 PM - SEC Filing
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide
March 22, 2024 4:30 PM - BizWire
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Ther
March 19, 2024 7:00 AM - BizWire
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Al
March 15, 2024 4:30 PM - BizWire
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
March 12, 2024 7:00 AM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Mar 07 Filed by: MAETZOLD DEREK J
March 11, 2024 5:19 PM - SEC Filing
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting
March 8, 2024 4:30 PM - BizWire
Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J
March 7, 2024 5:15 PM - SEC Filing
Castle Biosciences (CSTL) Reports New Data Confirming DecisionDx-SCC Provides Significant and Clinically Actionable Risk-Stratification of Patients
March 7, 2024 7:03 AM - StreetInsider
In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups
March 7, 2024 7:00 AM - BizWire
Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Juvenal Tobin W
March 6, 2024 6:08 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Oelschlager Kristen M
March 6, 2024 6:04 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: Stokes Frank
March 6, 2024 6:01 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: MAETZOLD DEREK J
March 6, 2024 5:59 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Mar 04 Filed by: BRADBURY DANIEL
March 6, 2024 5:53 PM - SEC Filing
Form 144 CASTLE BIOSCIENCES INC Filed by: MAETZOLD DEREK J
March 5, 2024 7:14 PM - SEC Filing
Castle Biosciences (CSTL) PT Raised to $37 at Scotiabank
March 1, 2024 7:06 AM - StreetInsider
Castle Biosciences (CSTL) PT Raised to $28 at KeyBanc
March 1, 2024 5:22 AM - StreetInsider
Castle Biosciences (CSTL) PT Raised to $33 at Baird
February 29, 2024 6:54 AM - StreetInsider
Castle Biosciences (CSTL) Files $300M Mixed Shelf
February 28, 2024 5:27 PM - StreetInsider
Form S-8 CASTLE BIOSCIENCES INC
February 28, 2024 5:27 PM - SEC Filing
Form S-3 CASTLE BIOSCIENCES INC
February 28, 2024 5:26 PM - SEC Filing
Castle Biosciences Inc. (CSTL) Tops Q4 EPS by 48c ; Offers Guidance
February 28, 2024 4:21 PM - StreetInsider
Form 10-K CASTLE BIOSCIENCES INC For: Dec 31
February 28, 2024 4:13 PM - SEC Filing
Form 8-K CASTLE BIOSCIENCES INC For: Feb 28
February 28, 2024 4:13 PM - SEC Filing
Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results
February 28, 2024 4:05 PM - BizWire
Castle Biosciences Inc. (CSTL) Announces Study Finds DecisionDx-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma
February 26, 2024 7:01 AM - StreetInsider
Study Finds DecisionDx®-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging
February 26, 2024 7:00 AM - BizWire
Form SC 13G CASTLE BIOSCIENCES INC Filed by: Granahan Investment Management, LLC
February 14, 2024 9:00 AM - SEC Filing
Form SC 13G/A CASTLE BIOSCIENCES INC Filed by: VANGUARD GROUP INC
February 13, 2024 6:09 PM - SEC Filing
Form SC 13G CASTLE BIOSCIENCES INC Filed by: PRINCIPAL GLOBAL INVESTORS
February 13, 2024 2:08 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Feb 07 Filed by: BRADBURY DANIEL
February 9, 2024 4:49 PM - SEC Filing
Form SC 13G/A CASTLE BIOSCIENCES INC Filed by: WASATCH ADVISORS LP
February 9, 2024 12:44 PM - SEC Filing
Form 4 CASTLE BIOSCIENCES INC For: Feb 05 Filed by: BRADBURY DANIEL
February 7, 2024 4:19 PM - SEC Filing
Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024
February 7, 2024 7:00 AM - BizWire
Form 144 CASTLE BIOSCIENCES INC Filed by: BRADBURY DANIEL
February 5, 2024 5:04 PM - SEC Filing
Castle Biosciences (CSTL) PT Raised to $31 at Baird
January 29, 2024 6:26 AM - StreetInsider
Form SC 13G/A CASTLE BIOSCIENCES INC Filed by: BlackRock Inc.
January 25, 2024 1:51 PM - SEC Filing
Full Article List
